Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$65.71 - $74.53 $670,833 - $760,876
10,209 Added 279.39%
13,863 $960,000
Q4 2022

Jan 19, 2023

SELL
$68.48 - $81.09 $6,300 - $7,460
-92 Reduced 2.46%
3,654 $0
Q3 2022

Oct 12, 2022

SELL
$0.13 - $76.84 $43,981 - $26 Million
-338,316 Reduced 98.9%
3,746 $257,000
Q2 2022

Jul 12, 2022

BUY
$72.62 - $79.98 $9.15 Million - $10.1 Million
125,970 Added 58.29%
342,062 $26.3 Million
Q1 2022

Apr 19, 2022

SELL
$61.48 - $73.72 $1.34 Million - $1.61 Million
-21,843 Reduced 9.18%
216,092 $16.7 Million
Q4 2021

Jan 26, 2022

BUY
$53.63 - $62.52 $12.8 Million - $14.9 Million
237,935 New
237,935 $14.8 Million
Q3 2021

Oct 18, 2021

SELL
$59.17 - $69.31 $25.7 Million - $30.1 Million
-434,357 Closed
0 $0
Q2 2021

Jul 23, 2021

BUY
$61.91 - $67.42 $2.72 Million - $2.96 Million
43,957 Added 11.26%
434,357 $28.9 Million
Q1 2021

Apr 19, 2021

BUY
$59.34 - $66.74 $23.2 Million - $26.1 Million
390,400 New
390,400 $24.4 Million
Q4 2020

Jan 25, 2021

SELL
$57.74 - $65.43 $254,344 - $288,219
-4,405 Closed
0 $0
Q2 2020

Jul 13, 2020

SELL
$54.82 - $64.09 $4.26 Million - $4.98 Million
-77,662 Reduced 94.63%
4,405 $262,000
Q1 2020

Apr 09, 2020

BUY
$46.4 - $67.43 $3.59 Million - $5.22 Million
77,345 Added 1637.97%
82,067 $4.57 Million
Q4 2019

Jan 29, 2020

BUY
$49.21 - $64.19 $3,641 - $4,750
74 Added 1.59%
4,722 $315,000
Q3 2019

Oct 09, 2019

BUY
$42.77 - $50.71 $198,794 - $235,700
4,648 New
4,648 $229,000
Q2 2019

Jul 25, 2019

SELL
$44.62 - $49.34 $1.37 Million - $1.52 Million
-30,801 Closed
0 $0
Q1 2019

Apr 09, 2019

BUY
$45.12 - $53.8 $887,600 - $1.06 Million
19,672 Added 176.76%
30,801 $1.45 Million
Q4 2018

Jan 17, 2019

BUY
$48.76 - $63.23 $357,898 - $464,108
7,340 Added 193.72%
11,129 $578,000
Q3 2018

Oct 19, 2018

SELL
$55.19 - $62.25 $18.7 Million - $21 Million
-337,984 Reduced 98.89%
3,789 $235,000
Q2 2018

Jul 09, 2018

SELL
$50.53 - $62.98 $464,269 - $578,660
-9,188 Reduced 2.62%
341,773 $21.6 Million
Q1 2018

Apr 09, 2018

BUY
$59.92 - $68.98 $2.45 Million - $2.82 Million
40,835 Added 13.17%
350,961 $22.2 Million
Q4 2017

Feb 13, 2018

BUY
$59.94 - $65.35 $981,157 - $1.07 Million
16,369 Added 5.57%
310,126 $19 Million
Q3 2017

Nov 01, 2017

BUY
$55.23 - $63.74 $331,435 - $382,503
6,001 Added 2.09%
293,757 $18.7 Million
Q2 2017

Aug 09, 2017

BUY
N/A
287,756
287,756 $16 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Polaris Wealth Advisory Group, LLC Portfolio

Follow Polaris Wealth Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polaris Wealth Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polaris Wealth Advisory Group, LLC with notifications on news.